Jiajin Feng

Title: Jiajin Feng: Innovator in Pharmaceutical Synthesis

Introduction

Jiajin Feng is a notable inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of methods for preparing temsirolimus. With a total of 2 patents, his work showcases innovative approaches to complex chemical processes.

Latest Patents

Feng's latest patents include two methods for preparing temsirolimus. The first patent describes a method that involves using a substituted aromatic aldehyde to protect 2,2-dimethylol propionic acid, leading to the production of an intermediate. This intermediate undergoes a reaction with 2,4,6-trichlorobenzoyl chloride, followed by a condensation reaction with rapamycin to yield another intermediate. Finally, sulfuric acid is used to remove the protecting group, resulting in temsirolimus. The second patent outlines a similar method, but it utilizes a substituted boric acid for protection instead. This method also involves a series of reactions culminating in the synthesis of temsirolimus.

Career Highlights

Throughout his career, Jiajin Feng has worked with various companies, including Tianjin Weijie Technology Co., Ltd. and Tianjin Wiejie Technology Co., Ltd. His expertise in chemical synthesis has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Feng has collaborated with notable colleagues such as Honghai Song and Long Tang. These partnerships have likely contributed to the advancement of his research and the successful development of his patented methods.

Conclusion

Jiajin Feng's innovative work in the synthesis of temsirolimus highlights his significant contributions to pharmaceutical chemistry. His patents reflect a deep understanding of complex chemical processes and a commitment to advancing medical science.